Cargando…
A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology
Models that recapitulate the complexity of human tumors are urgently needed to develop more effective cancer therapies. We report a bank of human patient-derived xenografts (PDXs) and matched organoid cultures from tumors that represent the greatest unmet need: endocrine-resistant, treatment-refract...
Ejemplares similares
-
An immune-humanized patient-derived xenograft model of estrogen-independent, hormone receptor positive metastatic breast cancer
por: Scherer, Sandra D., et al.
Publicado: (2021) -
Toward improved models of human cancer
por: Welm, Bryan E., et al.
Publicado: (2021) -
Estrogen-independent molecular actions of mutant estrogen receptor 1 in endometrial cancer
por: Blanchard, Zannel, et al.
Publicado: (2019) -
Immunologically “cold” triple negative breast cancers engraft at a higher rate in patient derived xenografts
por: Petrosyan, Varduhi, et al.
Publicado: (2022) -
The lingering mysteries of metastatic recurrence in breast cancer
por: Riggio, Alessandra I., et al.
Publicado: (2020)